Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epimaz 200mg tablets
0408010C0BCABAC
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Epimaz 400mg tablets
0408010C0BCACAD
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Epimaz Retard 200mg tablets
0408010C0BCADAG
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Epimaz Retard 400mg tablets
0408010C0BCAEAH
|
Epimaz | Carbamazepine | Central Nervous System | No data available |
|
Episenta 1g/10ml solution for injection ampoules
0408010W0BIAFBU
|
Episenta | Sodium valproate | Central Nervous System | No data available |
|
Eptadone 1mg/ml oral solution
0410030C0BHABAA
|
Eptadone | Methadone hydrochloride | Central Nervous System | No data available |
|
Eptadone 5mg/ml oral solution
0410030C0BHAABM
|
Eptadone | Methadone hydrochloride | Central Nervous System | No data available |
|
Equasym 10mg tablets
0404000M0BCABAA
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Equasym 20mg tablets
0404000M0BCACAK
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Equasym 5mg tablets
0404000M0BCAAAJ
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Erastig 4.6mg/24hours transdermal patches
0411000E0BFAAAF
|
Erastig | Rivastigmine | Central Nervous System | No data available |
|
Erastig 9.5mg/24hours transdermal patches
0411000E0BFABAG
|
Erastig | Rivastigmine | Central Nervous System | No data available |
|
Erenumab 140mg/1ml inj pre-filled disposable devices
0407042T0AAABAB
|
Erenumab | Erenumab | Central Nervous System | No data available |
|
Erenumab 70mg/1ml inj pre-filled disposable devices
0407042T0AAAAAA
|
Erenumab | Erenumab | Central Nervous System | No data available |
|
Ergotamine tartrate 2mg / Caffeine 100mg suppositories
0407041F0AAAHAH
|
Ergotamine tartrate | Ergotamine tartrate | Central Nervous System | No data available |
|
Escitalopram 10mg orodispersible tablets sugar free
0403030X0AAAHAH
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Escitalopram 10mg/ml oral drops sugar free
0403030X0AAADAD
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Escitalopram 15mg orodispersible tablets sugar free
0403030X0AAAIAI
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Escitalopram 20mg orodispersible tablets sugar free
0403030X0AAAJAJ
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Escitalopram 5mg orodispersible tablets sugar free
0403030X0AAAGAG
|
Escitalopram | Escitalopram | Central Nervous System | No data available |
|
Esperal 500mg tablets
0410010B0BCABAE
|
Esperal | Disulfiram | Central Nervous System | No data available |
|
Eszopiclone 1mg tablets
0401010AEAAAAAA
|
Eszopiclone | Eszopiclone | Central Nervous System | No data available |
|
Eszopiclone 2mg tablets
0401010AEAAABAB
|
Eszopiclone | Eszopiclone | Central Nervous System | No data available |
|
Eszopiclone 3mg tablets
0401010AEAAACAC
|
Eszopiclone | Eszopiclone | Central Nervous System | No data available |
|
Ethosuximide 500mg/5ml oral solution sugar free
0408010I0AAALAL
|
Ethosuximide | Ethosuximide | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.